INIS
receptors
100%
mice
100%
inflammation
83%
obesity
50%
diseases
33%
liver
33%
control
33%
accumulation
33%
levels
16%
comparative evaluations
16%
genetics
16%
detoxification
16%
Pharmacology, Toxicology and Pharmaceutical Science
Fatty Liver
100%
Advanced Glycation End Product
100%
Mouse Mutant
100%
Advanced Glycation End Product Receptor
100%
Inflammation
37%
Disease
12%
Receptor
12%
Inflammatory Disease
12%
Galectin 3
12%
Detoxication
12%
Glyoxalase
12%
Sterol Regulatory Element Binding Protein 1c
12%
Keyphrases
Obese Mice
100%
Advanced Glycation End Products
100%
Hepatosteatosis
100%
Obesity
23%
Inflammation
23%
Non-alcoholic Fatty Liver Disease (NAFLD)
23%
Detoxification
7%
Liver
7%
Chronic Inflammatory Diseases
7%
Sterol Regulatory Element-binding protein-1c (SREBP-1c)
7%
Galectin-3 (Gal-3)
7%
Genomic Deletion
7%
Receptor 1
7%
Inflammatory Pathways
7%
Glyoxalase
7%
Decreased Expression
7%
Lipogenic
7%
Liver-specific
7%
NLRP3 Pathway
7%
RAGE Expression
7%
Medicine and Dentistry
Fatty Liver
100%
Advanced Glycation End-Product
100%
Advanced Glycation End Product Receptor
100%
Non-Alcoholic Fatty Liver Disease
37%
Disease
12%
Signal Transduction
12%
Receptor
12%
Inflammatory Disorder
12%
Galectin 3
12%
Detoxication
12%
Glyoxalase
12%
Sterol Regulatory Element Binding Protein 1c
12%
Gene Deletion
12%
NLR Family Pyrin Domain containing 3
12%
Biochemistry, Genetics and Molecular Biology
Glycation
100%
Mouse Mutant
100%
Signal Transduction
7%
Galectin-3
7%
Gene Deletion
7%
Sterol Regulatory Element Binding Protein 1c
7%
Glyoxalase System
7%
NLR Family Pyrin Domain containing 3
7%
Immunology and Microbiology
Mouse Mutant
100%
Glycation
100%
Signal Transduction
7%
Inflammatory Disorder
7%
Sterol Regulatory Element Binding Protein 1c
7%
Galectin 3
7%
Gene Deletion
7%